Conventional medical care for IBS and FD has primarily focused dietary and lifestyle modifications to eliminate triggering factors typically include smoking cessation, regular sleep and exercise and avoiding foods known to affect the function of the GI tract, such as alcohol and caffeine (Stake-Nilsson et al., 2011).
The medical treatment for FD is intended to affect gastric acid, such as proton pump inhibitors (PPIs) and H2 receptor antagonists. The treatment options for IBS, such as anti-diarrhea, laxatives and anti-spasmodics, are primarily used to target individual symptoms. Newer medications approved for IBS include 5-HT3 receptor antagonists and chloride channel agonists (Gaman et al. 2009).
Although pharmacological therapies may temporarily relieve symptoms, they are often costly and may result in negative side effects (Gaylord et al. 2011)